Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis - Author's reply.

Kashour, Tarek; Tleyjeh, Imad M

Kashour, Tarek; Tleyjeh, Imad M.

Kashour T; Department of Cardiac Sciences, King Fahad Cardiac Center, King Saud University Medical City, Riyadh, Saudi Arabia.
Tleyjeh IM; Infectious Diseases Section, Department of Medical Specialties King Fahad Medical City, Riyadh, Saudi Arabia; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia; Division of Infectious Diseases, Mayo Clinic College of Medicine and Science, Rochester, MN, USA; Division of Epidemiology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA. Electronic address: Tleyjeh.Imad@mayo.edu.

Clin Microbiol Infect ; 27(8): 1177-1178, 2021 08.

Article in English | MEDLINE | ID: covidwho-1155452

Subject(s)

COVID-19 Drug Treatment; Antibodies, Monoclonal, Humanized/adverse effects; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Reviews / Systematic review/Meta Analysis Limits: Humans Language: English Journal: Clin Microbiol Infect Journal subject: Communicable Diseases / Microbiology Year: 2021 Document Type: Article Affiliation country: J.cmi.2021.02.024

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google